Avi Z. Naider insider trades: Loxo Oncology (LOXO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Avi reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 13, 2018 | LOXO | ↑ Buy | 725 | $138.92 | $101K | Direct | Dec 17, 2018 (4d) |
| Jan 22, 2018 | LOXO | ↓ Sell | 15,000 | $100.00 | $1.5M | Direct | Jan 25, 2018 (3d) |
| Oct 16, 2017 | LOXO | ↓ Sell | 5,000 | $90.00 | $450K | Direct | Oct 18, 2017 (2d) |
| Sep 18, 2017 | LOXO | ↓ Sell | 5,000 | $90.00 | $450K | Direct | Sep 20, 2017 (2d) |
| Sep 13, 2017 | LOXO | ↓ Sell | 5,000 | $90.00 | $450K | Direct | Sep 15, 2017 (2d) |
| Nov 17, 2015 | LOXO | ↑ Buy | 3,773 | $26.50 | $100K | Direct | Nov 19, 2015 (2d) |
| Aug 6, 2014 | LOXO | ↑ Buy | 3,846 | $13.00 | $50K | Direct | Aug 6, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Avi Z. Naider's insider trades
Avi Z. Naider is a director at Loxo Oncology (LOXO). Since Aug 6, 2014, Avi has reported 3 open-market purchases worth $251K and 4 sales worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), gifts (2 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LOXO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.